MINI FUTURE LONG - UCB Stock

DE000MG1L384

Market Closed - Börse Stuttgart 14:21:15 2024-06-13 EDT
3.46 ^EUR	+2.67%

Current month	+26.28%
1 month	+63.21%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart UCB

Latest news about UCB

UCB : Financial Reporting Document	06-13	PU
European shares steady after French political tremors, eyes on Fed	06-11	RE
UCB : Acquisition of own shares	05-31	PU
UCB : Commitment to Innovation in Drug Development	05-29	PU

More news

Quotes 5-day view

Date	Price	Change
24-06-13	3.46	+2.67%
24-06-12	3.37	+13.47%
24-06-11	2.97	+2.77%
24-06-10	2.89	+0.35%
24-06-07	2.88	+1.41%

Delayed Quote Börse Stuttgart

Last update June 13, 2024 at 02:21 pm

More quotes

Static data

Product type	Knock-Out with Stop Loss
Buy / Sell	CALL
Underlying	UCB
Issuer	Morgan Stanley
WKN	MG1L38
ISIN	DE000MG1L384
Date issued	2024-04-03
Strike	101.5 €
Maturity	Unlimited
Parity	10 : 1
Emission price	1.34 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	3.46 €
Lowest since issue	1.14 €

Company Profile

UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.

Sector

More about the company

Ratings for UCB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: UCB

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

136 EUR

Average target price

135 EUR

Spread / Average Target

-0.72%

Consensus